# Structure and dynamics of a multidomain nitric oxide synthase regulated by a C2 domain

**Authors:** Dhruva Nair, Brian R. Crane

PMC · DOI: 10.1126/sciadv.aeb4529 · Science Advances · 2026-02-20

## TL;DR

This paper reveals the structure and dynamic regulation of a multidomain nitric oxide synthase enzyme using cryo-electron microscopy.

## Contribution

The study provides the first detailed structural view of a full-length Synechococcus nitric oxide synthase with a regulatory C2 domain.

## Key findings

- The full-length Synechococcus NOS enzyme contains a regulatory C2 domain, a NOD module, and a pseudoglobin.
- Pterin binding is coupled to conformational changes in the oxygenase domain.
- The C2 domain moves over 85 angstroms to regulate either the NOS or NOD heme center.

## Abstract

Nitric oxide synthase (NOS) is a widely studied multidomain redox enzyme that produces the key signaling molecule and cytotoxic agent nitric oxide (NO) for functions that range from mammalian vasodilation to prokaryotic antibiotic resistance. NOS enzymes from metazoans and cyanobacteria rely on dynamic associations of their oxygenase and coupled diflavin reductase domains that have largely evaded detailed structural characterization. Cryo–electron microscopy studies of a representative dimeric six-domain Synechococcus NOS reveal the architecture of the full-length enzyme, which contains an unusual regulatory C2 domain, and additional nitric oxide dioxygenase (NOD) and pseudoglobin modules. Five distinct structural states depict how pterin binding couples to tight and loose oxygenase conformations and how the Ca2+-sensitive C2 domain moves over 85 angstroms to alternatively regulate either the NOS or NOD heme center. The extended carboxyl-terminal tail and its dynamic interactions highlight an added layer of regulation required by multidomain NOSs compared to other diflavin reductases.

syNOS is a highly dynamic multidomain oxidoreductase that harnesses a Ca2+-sensitive C2 domain to modulate activity.

## Linked entities

- **Proteins:** NOS1 (nitric oxide synthase 1)
- **Chemicals:** nitric oxide (PubChem CID 145068), NO (PubChem CID 24822), pterin (PubChem CID 135398660), Ca2+ (PubChem CID 271)
- **Species:** Synechococcus (taxon 1129)

## Full-text entities

- **Genes:** MFSD11 (major facilitator superfamily domain containing 11) [NCBI Gene 79157] {aka ET}, NOS1 (nitric oxide synthase 1) [NCBI Gene 4842] {aka IHPS1, N-NOS, NC-NOS, NOS, bNOS, nNOS}, NOS2 (nitric oxide synthase 2) [NCBI Gene 4843] {aka HEP-NOS, INOS, NOS, NOS2A}, Por (cytochrome p450 oxidoreductase) [NCBI Gene 29441] {aka CYPOR}, POR (cytochrome p450 oxidoreductase) [NCBI Gene 5447] {aka CPR, CYPOR, P450R}, oxidoreductase [NCBI Gene 9538117], Tnnt2 (troponin T2, cardiac type) [NCBI Gene 24837] {aka CTTG, Ctt, RATCTTG, Tnnt3}, NOS3 (nitric oxide synthase 3) [NCBI Gene 4846] {aka EC-NOS, ECNOS, MYMY8, NOSIII, cNOS, eNOS}, CAT [NCBI Gene 2847485], Nos3 (nitric oxide synthase 3) [NCBI Gene 24600] {aka eNos}, ATN1 (atrophin 1) [NCBI Gene 1822] {aka B37, CHEDDA, D12S755E, DRPLA, HRS, NOD}, Nos1 (nitric oxide synthase 1) [NCBI Gene 24598] {aka bNOS}
- **Diseases:** cancer (MESH:D009369), XL (MESH:D000080345), cytotoxic (MESH:D064420)
- **Chemicals:** EDTA (MESH:D004492), FMNH2 (MESH:C540087), nitrogen (MESH:D009584), NO2- (MESH:D009585), isoalloxazine (MESH:C008173), acetonitrile (MESH:C032159), hydroquinone (MESH:C031927), NaCl (MESH:D012965), CaCO3 (MESH:D002119), methionine (MESH:D008715), Oxygen (MESH:D010100), zinc (MESH:D015032), Nitrate (MESH:D009566), formic acid (MESH:C030544), TCEP (MESH:C080938), l-citrulline (MESH:D002956), ascorbate (MESH:D001205), SDS (MESH:D012967), NO3- (MESH:C038619), biotin (MESH:D001710), DTT (MESH:D004229), CaCl2 (MESH:D002122), NO (MESH:D009569), nicotinamide (MESH:D009536), phospholipid (MESH:D010743), ethane (MESH:D004980), NADP(+/H) (MESH:D009249), ZnCl2 (MESH:C016837), BH4 (MESH:C003402), Nitrite (MESH:D009573), heme (MESH:D006418), Asp (MESH:D001224), 3-(2-hydroxy-1-methyl-2-nitrosohydrazino)-N-methyl-1-propanamine (MESH:C115239), Arg (MESH:D001120), FAD (MESH:D005182), CRYOLO (-), superoxide (MESH:D013481), deuterium (MESH:D003903), pterin (MESH:D011622), glycerol (MESH:D005990), Hepes (MESH:D006531), Trp (MESH:D014364), hydrogen (MESH:D006859), lysine (MESH:D008239), flavin (MESH:C024132), sodium dithionate (MESH:C004850), potassium ferrocyanide (MESH:C031835), NADH (MESH:D009243), FADH2 (MESH:C058805), EGTA (MESH:D004533), tetrahydrofolate (MESH:C030371), FMN (MESH:D005486), CHES (MESH:C050927), cysteine (MESH:D003545)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Escherichia coli (E. coli, species) [taxon 562], Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606], Synechococcus (genus) [taxon 1129]
- **Mutations:** W677X, asparagine/glutamine, Glu1454(CTT), Glu1454, Lys-to-Lys, K987A, serine/threonine, Asn residue at the 1400 position, Arg1400Ser, Arg1400, P450, E2621L, Lys987, A to C
- **Cell lines:** PCC 7335 — Homo sapiens (Human), Transformed cell line (CVCL_EJ48), RAW — Mus musculus (Mouse), Mouse leukemia, Cancer cell line (CVCL_F681), BL21(DE3) — Mus musculus (Mouse), Hybridoma (CVCL_B7HM)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12922734/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12922734/full.md

## References

93 references — full list in the complete paper: https://tomesphere.com/paper/PMC12922734/full.md

---
Source: https://tomesphere.com/paper/PMC12922734